Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quercetin in COPD
NCT06003270Phase 2Recruiting
- Sponsor
- Temple University
- Start
- Nov 2023
- Primary completion
- Feb 2025
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of quercetin in chronic obstructive pulmonary disease (COPD), sponsored by Temple University. Started Nov 2023; status: recruiting.
02
Drugs
quercetin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06003270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06003270.